4//SEC Filing
Rosenblum Mark J 4
Accession 0001615219-20-000027
CIK 0001615219other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 6:03 PM ET
Size
5.4 KB
Accession
0001615219-20-000027
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Common Stock
2020-03-23+30,000→ 30,000 totalExercise: $0.61Exp: 2030-03-22→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]25% of the options granted are fully vested on March 23, 2021, and quarterly vesting of the remaining options over 3 years
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001329154
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 6:03 PM ET
- Size
- 5.4 KB